Class | Patients, n | Controls, n | Crude OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|
Noncarriers | 1,242 | 1,089 | Â | Â |
T+SJV | 17 | 3 | 4.97 (1.45 to 17.0) | 6.18 (1.76 to 21.8) |
Any rMS | 44 | 17 | 2.27 (1.29 to 4.00) | 2.20 (1.20 to 4.01) |
rMS stratified by Align-GVGD gradeb | Â | |||
   C0 | 12 | 9 | 1.17 (0.49 to 2.79) | 1.39 (0.55 to 3.56) |
   C15 | 14 | 5 | 2.46 (0.88 to 6.84) | 1.82 (0.62 to 5.34) |
   C25 | 7 | 2 | 3.07 (0.64 to 14.8) | 2.47 (0.45 to 13.49) |
   C35 | 1 | 0 |    - |  |
   C45 | 0 | 0 |    - |  |
   C55 | 1 | 0 |    - |  |
   C65 | 9 | 1 | 7.89 (1.00 to 62.4) | 8.75 (1.06 to 72.2) |
rMS stratified by SIFT gradec | Â | |||
   S > 0.05 | 21 | 8 | 2.30 (1.02 to 5.22) | 1.99 (0.83 to 4.77) |
   0.05 ≥ S > 0.00 | 12 | 5 | 2.10 (0.74 to 5.99) | 1.91 (0.63 to 5.86) |
   S = 0.00 | 11 | 4 | 2.41 (0.77 to 7.59) | 3.03 (0.91 to 10.0) |
rMS stratified by PolyPhen-2 grade | Â | |||
   Benign | 16 | 7 | 2.00 (0.82 to 4.89) | 1.69 (0.64 to 4.41) |
   Possibly Dd | 10 | 6 | 1.46 (0.53 to 4.03) | 1.65 (0.55 to 4.89) |
   Probably De | 18 | 4 | 3.95 (1.33 to 11.7) | 3.87 (1.25 to 12.0) |